You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts
AstraZeneca
McKinsey
Moodys
McKesson

Last Updated: September 30, 2020

DrugPatentWatch Database Preview

Litigation Details for Shure Incorporated v. Clearone, Inc. (D. Del. 2019)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Shure Incorporated v. Clearone, Inc. (D. Del. 2019)

Docket   Start Trial Date Filed 2019-07-18
Court District Court, D. Delaware Date Terminated
Cause 35:1 Patent Infringement Assigned To Richard Gibson Andrews
Jury Demand Plaintiff Referred To
Patents 10,004,679; 10,004,812; 10,012,654; 10,023,608; 10,023,892; 10,029,015; 10,029,080; 10,031,080; 10,041,934; 10,064,813; 10,072,053; 10,081,665; 10,086,005; 10,086,010; 10,086,011; 10,086,051; 10,086,068; 10,086,072; 10,087,493; 10,112,021; 10,155,002; 10,155,065; 10,155,960; 10,493,035; 10,493,051; 10,493,103; 10,543,186; 10,543,192; 10,543,204; 10,556,008; 10,556,010; 10,556,024; 10,556,942; 10,558,394; 10,590,143; 10,590,182; 6,010,737; 6,028,057; 6,028,083; 6,031,155; 6,051,635; 6,074,684; 6,121,021; 6,121,027; 6,398,960; 6,590,113; 6,632,678; 6,635,017; 6,653,530; 6,723,556; 6,737,006; 7,009,087; 7,018,806; 7,049,143; 7,070,958; 7,081,248; 7,081,264; 7,087,432; 7,094,737; 7,143,812; 7,176,026; 7,182,956; 7,182,958; 7,186,411; 7,553,952; 7,565,248; 7,612,030; 7,612,073; 7,612,087; 7,612,176; 7,662,578; 7,666,616; 7,705,204; 7,723,565; 7,812,186; 7,820,186; 7,960,416; 8,003,627; 8,003,813; 8,003,836; 8,007,806; 8,008,006; 8,012,192; 8,013,112; 8,017,074; 8,017,980; 8,025,900; 8,049,064; 8,057,892; 8,063,004; 8,063,008; 8,063,015; 8,083,485; 8,205,624; 8,211,485; 8,278,043; 8,299,209; 8,558,057; 8,581,014; 8,581,040; 8,581,041; 8,581,043; 8,590,530; 8,608,812; 8,624,002; 8,624,048; 8,624,073; 8,636,813; 8,653,053; 8,704,007; 8,822,176; 8,952,064; 9,005,182; 9,006,224; 9,012,418; 9,018,210; 9,023,616; 9,040,049; 9,050,248; 9,056,072; 9,057,072; 9,074,005; 9,113,627; 9,121,028; 9,192,581; 9,200,002; 9,204,653; 9,210,924; 9,233,068; 9,233,083; 9,233,956; 9,616,031; 9,616,590; 9,662,398; 9,678,075; 9,708,636; 9,822,182; 9,878,017; 9,925,209; 9,951,112; 9,956,192
Link to Docket External link to docket
Biologic Drugs cited in Shure Incorporated v. Clearone, Inc.

The biologic drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Shure Incorporated v. Clearone, Inc. (D. Del. 2019)

Date Filed Document No. Description Snippet Link To Document
2020-06-01 204 Report and Recommendations design patent); and (4) the design patent relies on the disclosure of the '493 patent and claims… (N.D. Ill. Apr. 10, 2019)) The United States Patent and Trademark Office’s Patent Trial and Appeal…). 4 The '723 patent claims priority to the '493 patent. (D.I. 64 at…asserted patent; (2) name each defendant; (3) cite the patent that is allegedly infringed; (4) describe…infringes the design claimed in the '723 patent. (Id. at 10-15) The Court will take up these arguments External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKinsey
Merck
Dow
Medtronic
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.